MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 03.01.2026
Trinity Biotech plc DSO 2011-2026 | TRIB
DSO Jährlich Trinity Biotech plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 87.2 | - | - | - | 65.5 | 113 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 113 | 65.5 | 88.5 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
31.7 | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
83.4 | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
101 | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
Castle Biosciences
CSTL
|
49.2 | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Danaher Corporation
DHR
|
57 | $ 234.99 | -0.25 % | $ 172 B | USA |
 |
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | China |
 |
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | USA |
 |
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | China |
 |
DarioHealth Corp.
DRIO
|
85.8 | $ 12.98 | 6.97 % | $ 368 M |  Israel |
 |
DexCom
DXCM
|
85 | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.4 | 3.66 % | $ 108 K | USA |
 |
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 27.9 | -0.39 % | $ 844 M | USA |
 |
Guardant Health
GH
|
49.2 | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
30.8 | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
61.3 | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 214.0 | -1.51 % | $ 11 B | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 243.4 | -0.36 % | $ 44.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 177.06 | -0.64 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 5.77 | -3.27 % | $ 748 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 189.39 | -6.67 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
43.6 | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
72 | $ 68.27 | -1.59 % | $ 4.72 B | USA |
 |
Agilent Technologies
A
|
63.8 | $ 145.56 | -1.51 % | $ 44.3 B | USA |
 |
Biomerica
BMRA
|
57.7 | $ 2.83 | 1.8 % | $ 6.5 M | USA |
 |
Bioventus
BVS
|
92.3 | $ 8.0 | 5.12 % | $ 501 M | USA |
 |
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
28.1 | $ 23.85 | 2.49 % | $ 31 M | USA |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
51.3 | $ 6.63 | -0.08 % | $ 601 M | USA |
 |
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.64 | 1.75 % | $ 2.49 M | USA |